2-130341842-T-G
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_032357.4(CCDC115):āc.214A>Cā(p.Ser72Arg) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000819 in 977,356 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/25 in silico tools predict a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_032357.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCDC115 | NM_032357.4 | c.214A>C | p.Ser72Arg | missense_variant, splice_region_variant | 2/5 | ENST00000259229.7 | NP_115733.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCDC115 | ENST00000259229.7 | c.214A>C | p.Ser72Arg | missense_variant, splice_region_variant | 2/5 | 1 | NM_032357.4 | ENSP00000259229 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000199 AC: 2AN: 100626Hom.: 0 Cov.: 26
GnomAD3 exomes AF: 0.00000421 AC: 1AN: 237290Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 129180
GnomAD4 exome AF: 0.00000684 AC: 6AN: 876696Hom.: 0 Cov.: 31 AF XY: 0.00000452 AC XY: 2AN XY: 442316
GnomAD4 genome AF: 0.0000199 AC: 2AN: 100660Hom.: 0 Cov.: 26 AF XY: 0.0000220 AC XY: 1AN XY: 45418
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 01, 2021 | The c.214A>C (p.S72R) alteration is located in exon 2 (coding exon 2) of the CCDC115 gene. This alteration results from a A to C substitution at nucleotide position 214, causing the serine (S) at amino acid position 72 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 15, 2021 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals affected with CCDC115-related conditions. This variant is present in population databases (rs556226856, gnomAD 0.003%). This sequence change replaces serine, which is neutral and polar, with arginine, which is basic and polar, at codon 72 of the CCDC115 protein (p.Ser72Arg). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at